Asston Pharmaceuticals Limited (BOM:544445)
India · Delayed Price · Currency is INR 83.80
-0.69 (-0.82%)
At close: Jan 19, 2026
Asston Pharmaceuticals Revenue
Asston Pharmaceuticals had revenue of 77.08M INR in the quarter ending September 30, 2025, a decrease of -3.47%. This brings the company's revenue in the last twelve months to 244.84M. In the fiscal year ending March 31, 2025, Asston Pharmaceuticals had annual revenue of 250.39M with 60.65% growth.
Revenue (ttm)
244.84M
Revenue Growth
+60.65%
P/S Ratio
2.97
Revenue / Employee
n/a
Employees
n/a
Market Cap
726.16M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 250.39M | 94.53M | 60.65% |
| Mar 31, 2024 | 155.86M | 90.48M | 138.39% |
| Mar 31, 2023 | 65.38M | -30.61M | -31.89% |
| Mar 31, 2022 | 95.99M | 15.64M | 19.47% |
| Mar 31, 2021 | 80.34M | 55.36M | 221.60% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Mangalam Drugs & Organics | 2.38B |
| Zenith Drugs | 1.44B |
| Makers Laboratories | 1.31B |
| Godavari Drugs | 1.06B |
| Accretion Pharmaceuticals | 826.43M |
| Mercury Laboratories | 773.75M |
| Onyx Biotec | 663.87M |
| Shelter Pharma | 598.96M |